Literature DB >> 9927504

The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis.

Z Mallat1, T Nakamura, J Ohan, G Lesèche, A Tedgui, J Maclouf, R C Murphy.   

Abstract

Evidence for increased oxidant stress has been reported in human atherosclerosis. However, no information is available about the importance of in situ oxidant stress in relation to plaque stability. This information is relevant because the morbidity and mortality of atherosclerosis are essentially the consequences of acute ischemic syndromes due to unstable plaques. We studied 30 carotid atherosclerotic plaques retrieved by endarterectomy from 18 asymptomatic (stable plaques) and 12 symptomatic patients (unstable plaques). Four normal arteries served as controls. After lipid extraction and ester hydrolysis, quantitation of different indices of oxidant stress were analyzed, including hydroxyeicosatetraenoic acids (HETEs), epoxyeicosatetraenoic acids (EETs), ketoeicosatetraenoic acids (oxo-ETEs), and F2-isoprostanes using online reverse-phase high-performance liquid chromatography tandem mass spectrometry (LC/MS/MS). All measurements were carried out in a strictly double-blind procedure. We found elevated levels of the different compounds in atherosclerotic plaques. Levels of HETEs were 24 times higher than EETs, oxo-ETEs, or F2-isoprostanes. Levels of HETEs, but not those of EETs, oxo-ETEs or F2-isoprostanes, were significantly elevated in plaques retrieved from symptomatic patients compared with those retrieved from asymptomatic patients (1, 738 +/- 274 vs. 1,002 +/- 107 pmol/ micromol lipid phosphorous, respectively; P < 0.01). One monooxygenated arachidonate species, 9-HETE, which cannot be derived from known enzymatic reactions, was the most abundant and significant compound observed in plaques, suggesting that nonenzymatic lipid peroxidation predominates in advanced atherosclerosis and may promote plaque instability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927504      PMCID: PMC407895          DOI: 10.1172/JCI3985

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

Review 1.  Mammalian lipoxygenases: molecular structures and functions.

Authors:  S Yamamoto
Journal:  Biochim Biophys Acta       Date:  1992-10-30

2.  A FAST, SIMPLE AND RELIABLE METHOD FOR THE MICRODETERMINATION OF PHOSPHORUS IN BIOLOGICAL MATERIALS.

Authors:  W R MORRISON
Journal:  Anal Biochem       Date:  1964-02       Impact factor: 3.365

3.  IMPROVED PROCEDURE FOR THE EXTRACTION OF LIPIDS FROM HUMAN ERYTHROCYTES.

Authors:  H G ROSE; M OKLANDER
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

4.  Preparation of labeled molecules by exchange with oxygen-18 water.

Authors:  R C Murphy; K L Clay
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 5.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

Authors:  V Fuster; L Badimon; J J Badimon; J H Chesebro
Journal:  N Engl J Med       Date:  1992-01-23       Impact factor: 91.245

Review 6.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

Authors:  V Fuster; L Badimon; J J Badimon; J H Chesebro
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

7.  Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries.

Authors:  M Rosolowsky; J R Falck; J T Willerson; W B Campbell
Journal:  Circ Res       Date:  1990-03       Impact factor: 17.367

8.  A possible role for 15-lipoxygenase in atherogenesis.

Authors:  D Harats; M A Mulkins; E Sigal
Journal:  Trends Cardiovasc Med       Date:  1995 Jan-Feb       Impact factor: 6.677

9.  George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry.

Authors:  D M Small
Journal:  Arteriosclerosis       Date:  1988 Mar-Apr

10.  Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate.

Authors:  C Suarna; R T Dean; J May; R Stocker
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-10       Impact factor: 8.311

View more
  33 in total

1.  L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.

Authors:  Satoshi Imaizumi; Victor Grijalva; Mohamad Navab; Brian J Van Lenten; Alan C Wagner; G M Anantharamiah; Alan M Fogelman; Srinivasa T Reddy
Journal:  Drug Metab Lett       Date:  2010-08

2.  Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease.

Authors:  Mehdi H Shishehbor; Renliang Zhang; Hector Medina; Marie-Luise Brennan; Danielle M Brennan; Stephen G Ellis; Eric J Topol; Stanley L Hazen
Journal:  Free Radic Biol Med       Date:  2006-09-08       Impact factor: 7.376

3.  Walnuts change lipoprotein composition suppressing TNFα-stimulated cytokine production by diabetic adipocyte.

Authors:  Kamil Borkowski; Sun J Yim; Roberta R Holt; Robert M Hackman; Carl L Keen; John W Newman; Gregory C Shearer
Journal:  J Nutr Biochem       Date:  2019-03-28       Impact factor: 6.048

4.  Presence of glucose in dialyzing fluid and synthesis of selected lipoxygenase-derived eicosanoids during hemodialysis.

Authors:  Barbara Dołęgowska; Wojciech Błogowski; Joanna Stępniewska; Krzysztof Safranow; Katarzyna Jakubowska; Maria Olszewska
Journal:  Int Urol Nephrol       Date:  2011-11-30       Impact factor: 2.370

5.  Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine.

Authors:  H Li; J A Lawson; M Reilly; M Adiyaman; S W Hwang; J Rokach; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 6.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

7.  Quantitative determination of esterified eicosanoids and related oxygenated metabolites after base hydrolysis.

Authors:  Oswald Quehenberger; Signe Dahlberg-Wright; Jiang Jiang; Aaron M Armando; Edward A Dennis
Journal:  J Lipid Res       Date:  2018-10-15       Impact factor: 5.922

8.  Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation.

Authors:  B F McAdam; I A Mardini; A Habib; A Burke; J A Lawson; S Kapoor; G A FitzGerald
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

9.  Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.

Authors:  Helen E Smith; J P Jones; Thomas F Kalhorn; Federico M Farin; Patricia L Stapleton; Connie L Davis; James D Perkins; David K Blough; Mary F Hebert; Kenneth E Thummel; Rheem A Totah
Journal:  Pharmacogenet Genomics       Date:  2008-11       Impact factor: 2.089

10.  Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.

Authors:  Amir Ravandi; Saeid Babaei; Ramsey Leung; Juan Carlos Monge; George Hoppe; Henry Hoff; Hiroshi Kamido; Arnis Kuksis
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.